| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9371 |
| Human Intestinal Absorption | HIA+ | 0.7936 |
| Caco-2 Permeability | Caco2- | 0.5823 |
| P-glycoprotein Substrate | Non-substrate | 0.8753 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9910 |
| Non-inhibitor | 0.9925 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9574 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7969 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8356 |
| CYP450 2D6 Substrate | Non-substrate | 0.8960 |
| CYP450 3A4 Substrate | Non-substrate | 0.7957 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8950 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9277 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9383 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9383 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9593 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9907 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9615 |
| Non-inhibitor | 0.9881 |
| AMES Toxicity | Non AMES toxic | 0.9375 |
| Carcinogens | Non-carcinogens | 0.5568 |
| Fish Toxicity | High FHMT | 0.6584 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8996 |
| Honey Bee Toxicity | High HBT | 0.7956 |
| Biodegradation | Ready biodegradable | 0.9750 |
| Acute Oral Toxicity | III | 0.4808 |
| Carcinogenicity (Three-class) | Non-required | 0.7062 |